Currently Investigating
Actos (pioglitazone), a drug used to treat Type 2 Diabetes and manufactured by Takeda Pharmaceuticals, has been linked to an increased rate of developing Bladder Cancer, the fourth most common form of cancer. The drug has been pulled off the shelves in many European countries including France and Germany. In June 2011, the US Food & Drug Association announced that taking Actos for more than one year may be associated with an increased risk of developing Bladder Cancer. Actos has also been sold under the trade names ActoplusMet, Actoplus Met XR, Competact, and Duetact
Common symptoms of Bladder Cancer include:
- Frequent Urination
- Blood in Urine
- Painful Urination
- Feeling of Need to Urninate/Urgency
If you or a loved one took Actos and have been diagnosed with Bladder Cancer, please CONTACT US through this web site, via email (click below), or call us TOLL FREE - 866-252-3535.
Yaz, Yasmin, and Ocella are combined oral contraceptives that contain ethinyl estradiol, long used in oral contraceptives, and drospirenone, a new type of progestin that is not used in any other birth control pills approved in the United States.
The warnings for Yaz and Yasmin are simply inadequate; they do not properly indicate that the use of drospirenone increases the risk that women may suffer a variety of side effects, such as:
- Strokes
- Heart attacks
- Pulmonary Embolism (PE)
- Deep Vein Thrombosis (DVT)
- Liver Disease
- Gallbladder Disease
- Kidney Failure
- Sudden Death
Drosprenone can increase blood potassium levels, potentially resulting in a condition known as hyperkalemia, which is known to disrupt heart rhythms and potentially lead to death. Individuals who have pre-existing kidney, liver and adrenal disease could be particularly susceptible.
If you or a loved one took Yaz or Yasmin and suffered side effects, please CONTACT US through this web site, via email (click below), or call us TOLL FREE - 866-252-3535.
Heparin is given as a blood thinner to treat or prevent clotting complications. Today, Heparin is the anti-coagulant of choice and one of the most commonly used drugs in the United States, administered to approximately 12 million patients each year in a variety of surgical settings.
Heparin Induced Thrombocytopenia (HIT), sometimes called White Clot Disorder, Heparin Allergy, or HIT II, is a serious antibody mediated reaction resulting from irreversible aggregation of platelets. HIT develops from a patient’s reaction to heparin, resulting in the accumulation of “heparin antibodies” which can progress to HIT.
HIT attacks platelets in the blood, and sometimes the lining of the blood vessels. HIT produces the opposite result from that for which the heparin is being used; it causes rather than prevents clotting. HIT in its most dangerous form is a severe clotting of the platelets which form white clots (from which the term “white clot disorder” derived). Even minimal exposure to Heparin from IV flushes or heparin coatings on catheters can cause HIT.
The consequences of HIT can be devastating, with internal clotting that can lead to heart attacks, limb amputations, strokes, and death. Other serious consequences of HIT include pulmonary embolism, deep vein thrombosis (“DVT”), thromboembolism (blood clots) skin lesions at injection sites, limb ischemia, swelling, gangrene, necrotic adrenal glands, organ failure, acute inflammatory responses, and other complications.
The following are some of the more common procedures and medical conditions in which heparin is often used:
►OPEN HEART SURGERY With heart surgery of any kind, including bypass and transplant, heparin is a standard therapy for a variety of purposes.
►HEART ATTACK Heparin is used to treat heart attacks.
►GENERAL HEART PATIENTS Heparin may be used therapeutically for heart patients, and it may also be used to avoid clots during the placement of stents (which can themselves be coated with heparin), and during heart catheterization procedure (which catheters also may be coated with heparin).
►KNEE, HIP, OR JOINT REPLACEMENT, AND OTHER ORTHOPAEDIC SURGERIES Heparin is a standard therapy given in advance of joint replacement surgery and after surgery to prevent blood clots from developing.
►STROKE (blood clot in the brain) Heparin is used as a therapy in the treatment of stroke.
►DEEP VEIN THROMBOSIS (DVT) Heparin is a standard treatment for DVT as well as other thrombosis.
Leading pharmaceutical manufacturers and medical researchers estimate 360,000 to 600,000 patients per year develop Heparin-Induced Thrombocytopenia. Of those patients that develop HIT, it is estimated that 50% develop blood clots called thromboemboli (an estimated 180,000 to 300,000 annual cases), and, of those patients, 10% to 20% face limb amputation (an estimated 18,000 to 60,000 annual cases), and 20% to 30% face death (an estimated 36,000 to 90,000). Survivors of HIT also face residual deficits related to strokes, heart attacks and pulmonary emboli.
If you or someone you love has lost a limb or suffered a serious injury during or after surgery, it may have been the result of Heparin-Induced Thrombocytopenia.
For a a case evaluation, please CONTACT US through this web site, via email (click below), or call us TOLL FREE - 866-252-3535.
|
